 |
|
Elevated pepsin levels may lead to rejection of lung transplants
June 18, 2007Researchers in the United Kingdom have demonstrated that high levels of pepsin, a digestive enzyme that is a marker for gastric aspiration, are associated with acute rejection of a lung transplant. This research provides further evidence that lung rejection may be caused by factors other than alloimmunity, the attack the body mounts to protect itself against "foreign" cells.
"We think gastric aspiration [the taking of stomach fluids into the lung] may contribute to an overall injury to the transplanted lung," said Chris Ward, Ph.D., lead author of the study. "This pattern of injury may be similar to rejection or increase the risk for further rejection."
Dr. Ward, of Newcastle University, and the other researchers reported their findings in the June 15, 2007, issue of American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.
The study included 36 lung transplant recipients, 17 subjects with normal lung function but unexplained cough who served as "disease controls" for the study, and 4 normal, nonsmoking control subjects. The researchers determined pepsin levels in all the subjects using bronchoalveolar lavage (BAL)
"Our primary finding was that, compared with control subjects," wrote the researchers, "BAL pepsin levels were elevated in stable lung transplant recipients, subjects with acute rejection, and subjects with bronciolitis obliterans [a common manifestation of lung transplant rejecton]. Our secondary finding was that the highest levels of pepsin appeared in the transplant recipients with clinically significant acute rejection (grade A2 or greater)."
These findings support the growing recognition that gastroesophageal reflux (GER) is a potential cause for post-transplant lung injury and other airway and lung diseases. Although none of the transplant patients were formally evaluated for GER, nearly all were treated with acid suppression medications, which is standard therapy after lung transplantation.
Despite those medications, known as proton pump inhibitors, the researchers found evidence of gastric aspiration. "It is important to recognize that proton pump inhibitors do not prevent reflux per se, but rather act to cut down on acidic reflux," the researchers noted. They also noted, that in addition to the damage that might be done to the new lung by acid reflux, pepsin is not targeted by these drugs and may be a separate cause of lung injury.
The researchers reported that the "disease control" group-those with normal lung function, but unexplained cough-did not have pepsin in their lungs, even when 10 of 17 were diagnosed during the study as having gastroesophageal reflux disease (GERD). "A diagnosis of GERD does not mean that patients are refluxing out of the esophagus and hence aspirating," they explained. "Even if the refluxate reaches the upper airway, it is almost certainly cleared by a hyperactive cough reflex."
In their article, the researchers note ongoing studies being done at Duke University that appear to show lung transplant patients who undergo fundoplication, a surgical procedure that strengthens the valve between the stomach and the esophagus, before the transplant have longer survival rates and delayed onset of bronchiolitis obliterans syndrome than those who do not.
If fundoplication is confirmed as a useful prophylaxis in preventing lung rejection, they write, "markers of aspiration may contribute to identifying patients who might derive clinical benefit."
American Thoracic Society
The study included 36 lung transplant recipients, 17 subjects with normal lung function but unexplained cough who served as "disease controls" for the study, and 4 normal, nonsmoking control subjects. The researchers determined pepsin levels in all the subjects using bronchoalveolar lavage (BAL)
"Our primary finding was that, compared with control subjects," wrote the researchers, "BAL pepsin levels were elevated in stable lung transplant recipients, subjects with acute rejection, and subjects with bronciolitis obliterans [a common manifestation of lung transplant rejecton]. Our secondary finding was that the highest levels of pepsin appeared in the transplant recipients with clinically significant acute rejection (grade A2 or greater)."
These findings support the growing recognition that gastroesophageal reflux (GER) is a potential cause for post-transplant lung injury and other airway and lung diseases. Although none of the transplant patients were formally evaluated for GER, nearly all were treated with acid suppression medications, which is standard therapy after lung transplantation.
Despite those medications, known as proton pump inhibitors, the researchers found evidence of gastric aspiration. "It is important to recognize that proton pump inhibitors do not prevent reflux per se, but rather act to cut down on acidic reflux," the researchers noted. They also noted, that in addition to the damage that might be done to the new lung by acid reflux, pepsin is not targeted by these drugs and may be a separate cause of lung injury.
The researchers reported that the "disease control" group-those with normal lung function, but unexplained cough-did not have pepsin in their lungs, even when 10 of 17 were diagnosed during the study as having gastroesophageal reflux disease (GERD). "A diagnosis of GERD does not mean that patients are refluxing out of the esophagus and hence aspirating," they explained. "Even if the refluxate reaches the upper airway, it is almost certainly cleared by a hyperactive cough reflex."
In their article, the researchers note ongoing studies being done at Duke University that appear to show lung transplant patients who undergo fundoplication, a surgical procedure that strengthens the valve between the stomach and the esophagus, before the transplant have longer survival rates and delayed onset of bronchiolitis obliterans syndrome than those who do not.
If fundoplication is confirmed as a useful prophylaxis in preventing lung rejection, they write, "markers of aspiration may contribute to identifying patients who might derive clinical benefit."
American Thoracic Society
Lung Transplant Current Events and Lung Transplant News RSSTest helps in fight against lung infections and for treating other life-threatening infections
A new test developed by Edmonton-based Innovotech™ Inc. will now allow doctors to more accurately identify the right antibiotics required to treat serious, chronic infections that are biofilm based.
Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients
The first findings from a one-of-a-kind, patient-driven effort to provide lung tissue for research might help doctors predict when patients with idiopathic pulmonary fibrosis (IPF) are becoming dangerously ill and also could point the way to interventions that could sustain them until life-saving transplants can be performed.
Women with cystic fibrosis can have safe and successful fertility treatment
Women with cystic fibrosis can have fertility treatment to help them have babies without any long-term adverse effects on either themselves or their children.
Gene therapy technique thwarts cancer by cutting off tumor blood supply
University of Florida researchers have come up with a new gene therapy method to disrupt cancer growth by using a synthetic protein to induce blood clotting that cuts off a tumor's blood and nutrient supply.
Protein may be strongest indicator of rare lung disease, study shows
Researchers at the University of Cincinnati (UC) have discovered a protein in the lungs that can help in determining progression of the rare lung disease Idiopathic Pulmonary Fibrosis (IPF).
Breathing life into injured lungs: World-first technique will expand lung donor organ pool
For the first time in the world, transplant surgeons at Toronto General Hospital, University Health Network used a new technique to repair an injured donor lung that was unsuitable for transplant, and then successfully transplanted it into a patient.
New clinical trial for patients with asbestos-associated lung cancer
The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by previous exposure to asbestos.
Depression and PTSD symptoms in caregivers of lung transplant patients
Symptoms of depression and post-traumatic stress disorder (PTSD) among caregivers of deceased lung transplant patients are four-to-five times more prevalent than in the average population, according to researchers who analyzed the stress levels of caregivers, as well as their perceptions of the transplant recipients' quality of dying and death.
UCSF marks a milestone with 500th transplant in heart and lung program
UCSF marked a milestone this week with the 500th procedure in its Thoracic Transplant Program, which specializes in transplantation of the heart and lung.
Lung transplants in cystic fibrosis patients with life-threatening bacteria sparks debate at ISHLT
During Wednesday's Satellite Symposium 3: The Challenges of Lung Transplantation in Cystic Fibrosis (CF) at the International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, clinicians and researchers discussed some of the unique challenges in achieving excellent lung transplant outcomes in patients with CF.
More Lung Transplant Current Events and Lung Transplant News Articles
 |
Blow the House Down: The Story Of My Double Lung Transplant by Charlie Tolchin (Author) What is it like to receive a life-saving organ transplant? On April 13, 1997, I received new lungs. Blow the House Down details my story. It illustrates how Cystic Fibrosis affected my life and how I fought it. This book reflects the immense generosity of so many people, including my donor and her family; my family and friends; people who donate to Cystic Fibrosis research and drive major scientific breakthroughs; and doctors, nurses, and physical therapists who toil hard day in and day out to restore our health. Together, we each have the power to cure disease. |
 |
The Lung Transplantation Handbook: A Guide For Patients, Second Edition by Karen A. Couture (Author) 'The Lung Transplantation Handbook (Second Edition)', originally published under the title 'Things You Should Know About Lung Transplantation: Before, During and After' has now been updated and expanded in this, the second edition. This comprehensive, 270-page book, written by lung transplant recipient Karen A. Couture, covers the entire transplantation process from beginning to end for both lung and heart-lung transplants. This book introduces the reader, in easy-to-understand language, to the complex process of getting on the transplant waiting list and how the list works; preparing for surgery and the surgery itself; financing the operation and the recovery afterward; and the complications of rejection and the medications. It also includes precautions a transplant recipient... |
|
Dying to Breathe ; Nova ; Lung Transplants Also With: NOVA (Primary Contributor) VHS-Advances in organ transplant surgery have improved the lives of many terminally ill patients. Along with the medical success of these procedures, however, comes a wide range of ethical and moral decisions for doctors, patients, and their families. Through profiles of some of the doctors and patients in the Toronto General Hospital Lung Transplant Program, this episode of NOVA provides a glimpse into the personal stories behind these difficult decisions. Each time a lung becomes available for transplant, doctors must determine within a few hours whether the organ is suitable for transplantation into a waiting patient. Although this surgical procedure makes it possible for doctors to save lives, many ethical issues have been raised as a result. This program illustrates many of the... | |
 |
Organ Transplant: Making a Match (Home Use) Part of the award winning public television series Healthy Body/Healthy Mind. About sixty years ago, successful organ transplants for humans began to show signs of success. Since then, organ transplants have saved millions of lives worldwide. More than 65,000 Americans are waiting for an organ transplant. While each day about 57 Americans receive a transplant, about 13 will die because not enough organs are available. Once a transplant has been completed, preventing the body's rejection of the transplanted organ can be an ongoing challenge. The body's attempt to destroy the transplanted organ; usually occurs in the first year after transplant. Rejection occurs when the body tries to attack a transplanted organ because it reacts to the organ or tissue as a foreign object and produces... |
 |
Taking Flight: Inspirational Stories of Lung Transplantation by Joanne M. Schum (Compiler) Lung Transplantation is still relatively new compared to other transplantation surgery. The first successful heart/lung transplant took place in 1981, with the first successful single lung transplant taking place in 1983. It was not until 1986 the first successful double lung transplant takes place. Even more recent is the living lobar transplant which the first successful one being in 1990. The survival rate continues to rise with the introduction of new surgery techniques, drug therapies and physical therapy. Often those given the option to have a lung transplant, have no place to turn and learn about the success and accomplishments of those receiving a single lung, double lung, or heart/lung transplant. It can become overwhelming being in the process of lung transplant and not... |
|
OrganArt Organ Donor Adult Long Sleeve T-Shirt White 2X by YoursOnDemand | |
 |
Lung Transplantation by Nicholas R. Banner (Editor), Julia M. Polak (Editor), Magdi H. Yacoub (Editor) This book provides a detailed account of the principles and practice of contemporary lung transplantation. An accomplished, international team of contributing authors have combined their expertise to provide the latest scientific developments and clinical knowledge based on their extensive experience. The book covers pulmonary vascular and parenchymal lung disease, which necessitate transplantation, together with all aspects of the multidisciplinary management of lung transplant patients. It concludes by looking at future developments in the treatment of advanced respiratory failure. |
 |
A Death Retold: Jesica Santillan, the Bungled Transplant, and Paradoxes of Medical Citizenship (Studies in Social Medicine) by Keith Wailoo (Editor), Julie Livingston (Editor), Peter Guarnaccia (Editor) In February 2003, an undocumented immigrant teen from Mexico lay dying in a prominent American hospital due to a stunning medical oversight—she had received a heart-lung transplantation of the wrong blood type. In the following weeks, Jesica Santillan's tragedy became a portal into the complexities of American medicine, prompting contentious debate about new patterns and old problems in immigration, the hidden epidemic of medical error, the lines separating transplant "haves" from "have-nots," the right to sue, and the challenges posed by "foreigners" crossing borders for medical care. This volume draws together experts in history, sociology, medical ethics, communication and immigration studies, transplant surgery, anthropology, and health law to understand the dramatic events, the... |
|
OrganArt Organ Donor Hooded Sweatshirt White Youth (10/12) by YoursOnDemand | |
 |
Manual of Lung Transplant Medical Care (Transplant Care Series) by Hertz (Author) Describes the optimal procedures to follow in the care of the lung transplant patient - beginning prior to the time of first referral and continuing through the rest of the patient's post-operative life. |
| © 2009 BrightSurf.com |